Letter abstract


Nature Cell Biology 5, 1095 - 1103 (2003)
Published online: 23 November 2003 | doi:10.1038/ncb1065

RGS16 inhibits signalling through the Galpha13–Rho axis

Eric N. Johnson1,5, Tammy M. Seasholtz2,5, Abdul A. Waheed3, Barry Kreutz4, Nobuchika Suzuki4, Tohru Kozasa4, Teresa L.Z. Jones3, Joan Heller Brown2 & Kirk M. Druey1

Top

Galpha13 stimulates the guanine nucleotide exchange factors (GEFs) for Rho, such as p115Rho-GEF1. Activated Rho induces numerous cellular responses, including actin polymerization, serum response element (SRE)-dependent gene transcription and transformation2. p115Rho-GEF contains a Regulator of G protein Signalling domain (RGS box) that confers GTPase activating protein (GAP) activity towards Galpha12 and Galpha13 (ref. 3). In contrast, classical RGS proteins (such as RGS16 and RGS4) exhibit RGS domain-dependent GAP activity on Galphai and Galphaq, but not Galpha12 or Galpha13 (ref 4). Here, we show that RGS16 inhibits Galpha13-mediated, RhoA-dependent reversal of stellation and SRE activation. The RGS16 amino terminus binds Galpha13 directly, resulting in translocation of Galpha13 to detergent-resistant membranes (DRMs) and reduced p115Rho-GEF binding. RGS4 does not bind Galpha13 or attenuate Galpha13-dependent responses, and neither RGS16 nor RGS4 affects Galpha12-mediated signalling. These results elucidate a new mechanism whereby a classical RGS protein regulates Galpha13-mediated signal transduction independently of the RGS box.

Top
  1. Molecular Signal Transduction Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases/National Institute of Health, Rockville, MD 20852, USA.
  2. Department of Pharmacology, University of California, San Diego, School of Medicine, San Diego, CA 92093, USA.
  3. Metabolic Disease Branch, National Institute of Diabetes, Digestive and Kidney Diseases/National Institute of Health, Bethesda, MD 20892, USA.
  4. Department of Pharmacology, University of Illinois, Chicago, IL 60612, USA.
  5. These authors contributed equally to this work.

Correspondence to: Kirk M. Druey1 e-mail: kdruey@niaid.nih.gov



MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

REVIEWS
REGULATORS OF G-PROTEIN SIGNALLING AS NEW CENTRAL NERVOUS SYSTEM DRUG TARGETS
Nature Reviews Drug Discovery Review Article (01 Mar 2002)
RGS-containing RhoGEFs: the missing link between transforming G proteins and Rho?
Oncogene Reviews (30 Mar 2001)
 See all 4 matches for Reviews

NEWS AND VIEWS
A new twist for the tumour suppressor hamartin
Nature Cell Biology News and Views (01 May 2000)

RESEARCH
Structure of the rgRGS domain of p115RhoGEF
Nature Structural Biology Letters (01 Sep 2001)
The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways
Oncogene Original Article (11 Apr 2001)
 See all 13 matches for Research


Extra navigation

Subscribe to Nature Cell Biology

Subscribe

Open Innovation Challenges

  • Optimizing Sub-cellular Localization Tags

    • Deadline: Jan 31 2010
    • Reward: $20,000 USD

    The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....

  • Single-cell Analysis Platform

    • Deadline: Dec 02 2009
    • Reward: $5,000 USD

    This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...